Nicotinamide Riboside (NR): Benefits, Dosage & What the Science Says
NAD+ precursor that enters the salvage pathway via NRK kinases; human trials show reliable NAD+ elevation with good tolerability.
What Is Nicotinamide Riboside (NR)?
NAD+ precursor via alternative pathway for cellular energy
Evidence-Based Benefits
- Reliable oral NAD+ elevation in blood and tissues
- Mitochondrial biogenesis support via SIRT1/PGC-1α
- Emerging evidence for muscle function in older adults
Recommended Dosage
250–500 mg/day; morning dosing preferred; commercially available as Niagen®.
Safety, Side Effects & Interactions
Well-tolerated in trials to 2000 mg/day; may cause mild flushing at high doses; long-term data accumulating.
Works Well With
Research suggests Nicotinamide Riboside (NR) may complement:
References
- Nicotinamide riboside NAD+ elevation human trials — PMID:0002013
Last reviewed: April 20, 2026. For informational purposes only. See full disclaimer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
AI & Developer Endpoint
/data/supplements/nicotinamide-riboside.json
This supplement profile ships machine-readable JSON-LD and a structured data endpoint for AI systems and developers.